MassDevice.com +5 | The top 5 medtech stories for August 23, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Power morcellation rates plunged after FDA warnings Use of electric power morcellation for hysterectomy procedures has significantly declined after the FDA warned against the use of such devices in 2014, according to a new study. Data from the study was published this month in the Journal of the American Medical Association. Read more 4. Opko Health gets in on BioCardia after merger with Tiger X Medical BioCardia said today that Opko Health agreed to pick up a “significant” stake in its business after a merger with Tiger X Medical. The new company will keep the BioCardia name and the development program for its CardiAMP cell therapy for heart failure patient’s who’ve had a heart attack. Stem cells derived from the bone marrow of patients likely to respond to the therapy, as indicated by testing for BioCardia’s biomarker, are delivered at a high dose using the Helix catheter. Read more 3. Medtronic closes $1B HeartWare buyout Medtronic said today that it’s closed the $1.1 billion acquisition of implantable cardiac pump maker HeartWare International. The ...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news